Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. SPY
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity

Alnylam Pharma (ALNY) Misses Q3 EPS by 15c

October 28, 2021 8:13 AM EDT

Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of ($1.72), $0.15 worse than the analyst estimate of ($1.57). Revenue for the quarter came in at $187.6 million versus the consensus estimate of $218.54 million.

2021 Financial Guidance

... More